BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Casson AG. Molecular biology of Barrett’s esophagus and esophageal cancer: role of p53World J Gastroenterol 1998; 4(4): 277-279 [PMID: 11819298 DOI: 10.3748/wjg.v4.i4.277]
URL: https://www.wjgnet.com/1007-9327/full/v4/i4/277.htm
Number Citing Articles
1
Alan G Casson. Role of molecular biology in the follow-up of patients who have Barrett's esophagusChest Surgery Clinics of North America 2002; 12(1): 93 doi: 10.1016/S1052-3359(03)00068-1
2
Ming-Yao Wu, Ying-Rui Liang, Xian-Ying Wu, Chu-Xiang Zhuang. Relationship between Egr-1 gene expression and apoptosis in esophageal carcinoma and precancerous lesionsWorld Journal of Gastroenterology 2002; 8(6): 971-975 doi: 10.3748/wjg.v8.i6.971
3
S. J. Walker, J. P. Byrne, N. Birbeck. What’s new in the pathology, pathophysiology and management of benign esophageal disorders?Diseases of the Esophagus 1999; 12(3): 219 doi: 10.1046/j.1442-2050.1999.00056.x
4
Miao-Wang Hao, Ying-Rui Liang, Yan-Fang Liu, Li Liu, Ming-Yao Wu, Huan-Xing Yang. Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell linesWorld Journal of Gastroenterology 2002; 8(2): 203-207 doi: 10.3748/wjg.v8.i2.203
5
Yan Li, Robert C.G. Martin. Apoptosis in Carcinogenesis and Chemotherapy2009; : 127 doi: 10.1007/978-1-4020-9597-9_6
6
Ming-Yao Wu, Mao-Huai Chen, Ying-Rui Liang, Guo-Zhao Meng, Huan-Xing Yang, Chu-Xiang Zhuang. Experimental and clinic-opathologic study on the relationship between transcription factor Egr-1 and esophageal carcinomaWorld Journal of Gastroenterology 2001; 7(4): 490-495 doi: 10.3748/wjg.v7.i4.490